Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas W Strand

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Molecular Oncology|August 7, 2013
SPARCL1 suppresses metastasis in prostate cancerYuzhu Xiang, Qingchao Qiu, Ming Jiang, et al.
The Prostate|June 5, 2020
Urethral luminal epithelia are castration-insensitive cells of the proximal prostateDiya B Joseph, Gervaise H Henry, Alicia Malewska, et al.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
The Journal of Urology|August 29, 2020
Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor ManagementRohit R Badia, Dreaux Abe, Daniel Wong, et al.
European Urology Open Science|May 17, 2021
Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node DissectionJohn T Lafin, Alexander P Kenigsberg, Xiaosong Meng, et al.
Scientific Reports|June 29, 2023
Refining the serum miR-371a-3p test for viable germ cell tumor detectionJohn T Lafin, Cinzia G Scarpini, Armon Amini, et al.
Disease Models & Mechanisms|July 28, 2021
A mechanism linking perinatal 2,3,7,8 tetrachlorodibenzo-p-dioxin exposure to lower urinary tract dysfunction in adulthoodAnne E Turco, Steven R Oakes, Kimberly P Keil Stietz, et al.
Cancer Cell|December 12, 2018
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical TrajectoriesClarissa Gerhauser, Francesco Favero, Thomas Risch, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Molecular Oncology|August 7, 2013
SPARCL1 suppresses metastasis in prostate cancerYuzhu Xiang, Qingchao Qiu, Ming Jiang, et al.
The Prostate|June 5, 2020
Urethral luminal epithelia are castration-insensitive cells of the proximal prostateDiya B Joseph, Gervaise H Henry, Alicia Malewska, et al.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
The Journal of Urology|August 29, 2020
Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor ManagementRohit R Badia, Dreaux Abe, Daniel Wong, et al.
European Urology Open Science|May 17, 2021
Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node DissectionJohn T Lafin, Alexander P Kenigsberg, Xiaosong Meng, et al.
Scientific Reports|June 29, 2023
Refining the serum miR-371a-3p test for viable germ cell tumor detectionJohn T Lafin, Cinzia G Scarpini, Armon Amini, et al.
Disease Models & Mechanisms|July 28, 2021
A mechanism linking perinatal 2,3,7,8 tetrachlorodibenzo-p-dioxin exposure to lower urinary tract dysfunction in adulthoodAnne E Turco, Steven R Oakes, Kimberly P Keil Stietz, et al.
Cancer Cell|December 12, 2018
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical TrajectoriesClarissa Gerhauser, Francesco Favero, Thomas Risch, et al.
Pageof 7